IGM Biosciences IGMS, a clinical-stage company, is developing a pipeline of Immunoglobin M (IgM) antibody-based candidates to treat patients with cancer and autoimmune and inflammatory diseases. The ...
IGM Biosciences, Inc.’s IGMS share price nearly doubled on Tuesday, after the company announced that it has entered into an exclusive partnership with Sanofi SNY to create, develop and commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback